2Knetki-Wr6blewska M,Kowalski DM, Zajda K, et al. Gefitinibin patients with advanced non-small-cell lung cancer [ J]. Pneu-monol Alergol Pol, 2012, 80(5) : 439 -449.
3Mohajeri G, Sanei MH, Tabatabaee SA, et al. Micrometastasis in non-small-cell lung cancer: Detection and staging [ J ]. Ann Thorae Med, 2012, 7(3): 149- 152.
4Ursino S, Fiorica E, Colosimo C, et al. Metabolic responses in non-small cell lung cancer after hypofractionated stereotactic ra- diotherapy PET and hypofractionated radiotherapy [ J ]. Eur Rev Med Pharmacol Sci, 2012, 16(6) : 755 -762.
5Aisner DL, Marshall CB. Molecular pathology of non-small celllung cancer: a practical guide [ J]. Am J Clin Pathol, 2012 ,138(3) : 332 -346.
6Knetki-Wróblewska Magdalena,Kowalski Dariusz M,Zajda Katarzyna,P?u?ański Adam,Badurak Pawe?,Janowicz-?ebrowska Anna,Ja?kiewicz Piotr,Krzakowski Maciej.[Gefitinib in patients with advanced non-small-cell lung cancer]. Pneumonologia i alergologia polska . 2012
7Dara L. Aisner,Carrie B. Marshall.Molecular Pathology of Non-Small Cell Lung Cancer A Practical Guide. AMERICAN JOURNAL OF CLINICAL PATHOLOGY . 2012
